Cargando…
Monoclonal Antibody Therapies against Anthrax
Anthrax is a highly lethal infectious disease caused by the spore-forming bacterium Bacillus anthracis. It not only causes natural infection in humans but also poses a great threat as an emerging bioterror agent. The lethality of anthrax is primarily attributed to the two major virulence factors: to...
Autores principales: | Chen, Zhaochun, Moayeri, Mahtab, Purcell, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3202866/ https://www.ncbi.nlm.nih.gov/pubmed/22069754 http://dx.doi.org/10.3390/toxins3081004 |
Ejemplares similares
-
A Bacteriophage T4 Nanoparticle-Based Dual Vaccine against Anthrax and Plague
por: Tao, Pan, et al.
Publicado: (2018) -
Role of N-Terminal Amino Acids in the Potency of Anthrax Lethal Factor
por: Gupta, Pradeep K., et al.
Publicado: (2008) -
Anthrax Lethal Toxin Downregulates Claudin-5 Expression in Human Endothelial Tight Junctions
por: D’Agnillo, Felice, et al.
Publicado: (2013) -
Anthrax Edema Factor Toxicity Is Strongly Mediated by the N-end Rule
por: Leysath, Clinton E., et al.
Publicado: (2013) -
Antibodies Against Anthrax: Mechanisms of Action and Clinical Applications
por: Froude, Jeffrey W., et al.
Publicado: (2011)